GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · BSE Equity Only

BSE Exchange Filings, Explained Simply

AI-powered plain-English analysis of every important BSE announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Today
—
Total
BSE
Exchange
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Strictly sourced from BSE exchange announcements (equity segment only). We show only material, important filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India exchange announcements. More categories will be added over time.
Dharti Proteins Ltd
Dharti Proteins Board Recommends 1:1 Bonus Shares
BONUS ▲ Positive Development LOW RISK
📅 Filed on BSE: 13 Oct 2026, 07:56 PM IST  ·  BSE ID: 23c5c85d-4f98-4d30-976e-9c798e79db62
View Original BSE Filing (PDF)
💡
In Simple Terms
Dharti Proteins will give existing public shareholders one free share for every share they own to meet listing rules.
🤖 AI Summary
  • Board recommends 1:1 bonus share issuance to public shareholders.
  • Each bonus share will be Rs. 10/- equity, for every 1 share held.
  • Bonus issue aims for compliance with minimum public shareholding rules.
  • Approved audited standalone financial results for H1 FY27.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Bonus Share Ratio
1:1
Bonus Share Face Value
Rs. 10/-
Financial Period
Quarter and half year ended September 30, 2026
🏢 How This Affects the Company
📈
Business Impact
The bonus issue is intended to increase the number of shares held by public shareholders, facilitating compliance with minimum public shareholding norms.
💰
Financial Impact
The bonus share issuance will not involve any cash outflow but will result in an increase in the company's equity share capital, impacting its capital structure.
⚠️
Risk Impact
Failure to comply with minimum public shareholding requirements could lead to regulatory action; this bonus issue addresses that specific risk.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders. Further details will be provided upon member approval.
👤
Who Is Affected
Public shareholders, excluding promoter and promoter group, will be allocated bonus shares in a 1:1 ratio.
🔍
Management Signal
Management is taking steps to ensure regulatory compliance regarding public shareholding requirements.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Shareholder approval for the bonus share issuance.
Announcement of the record date for bonus share eligibility.
Subsequent regulatory filings related to bonus share allotment.
LOW RISK The filing details a board recommendation for bonus shares and financial results approval.
💡 Investor Takeaway
Dharti Proteins recommended a 1:1 bonus share issuance for public shareholders, excluding promoters, to comply with minimum public shareholding rules. Audited H1 FY27 results were also approved.
⚖️ Strengths & Concerns

✅ Positives

  • Board's proactive recommendation of 1:1 bonus shares to meet public shareholding norms.
  • Approval of audited financial results for the half-year ended September 30, 2026.
❓ Frequently Asked Questions
What has Dharti Proteins' Board recommended regarding bonus shares?
The Board has recommended issuing bonus equity shares in the proportion of 1:1 for public shareholders, excluding the promoter and promoter group.
What is the face value of the bonus shares recommended by Dharti Proteins?
Each bonus equity share recommended by Dharti Proteins has a face value of Rs. 10/-.
Why is Dharti Proteins recommending bonus shares?
The bonus share issuance is recommended to achieve compliance with the minimum public shareholding requirement mandated under relevant rules.
What financial results did Dharti Proteins' Board approve?
The Board approved the audited standalone financial results for the quarter and half year ended September 30, 2026.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.